ORIGINAL RESEARCH article
Front. Gastroenterol.
Sec. Gastrointestinal Infection
Volume 4 - 2025 | doi: 10.3389/fgstr.2025.1619533
Prevalence of Celiac Disease in a Tunisian cohort
Provisionally accepted- 1Laboratory of Immunology, Farhat Hached University Hospital, Sousse, Tunisia
- 2Faculty of Pharmacy, Department of Immunology, University of Monastir, Monastir, Tunisia
- 3Research Laboratory for “Epidemiology and Immunogenetics of Viral Infections” (LR14SP02), Sahloul University Hospital, University of Sousse, Sousse, Tunisia
- 4Institute for Experimental Immunology, Euroimmun, Lübeck, Germany
- 5LR12SP11, Biochemistry Department, Sahloul University Hospital, Sousse, Tunisia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background Accurate and non-invasive diagnostics of celiac disease are essential for effective patient management. Although small intestine biopsy remains the diagnostic gold standard, serological assays offer a promising alternative. This study evaluated the performance and concordance of immunoblot, indirect immunofluorescence test (IIFT), and enzyme-linked immunosorbent assay (ELISA) in detecting celiac disease-specific autoantibodies in a Tunisian cohort, aiming to assess the potential of combining various assays to reduce reliance on invasive procedures. Methods Serum samples from 80 celiac disease patients and appropriate controls were analyzed using three serological methods. IIFT was employed to detect IgA autoantibodies against endomysium using primate liver and human umbilical cord substrates. ELISA was used to quantify anti-tissue transglutaminase (tTG) IgA and deamidated gliadin peptide (DGP) autoantibodies. Immunoblots assessed additional autoantibodies (tTG, GAF-3X, and ASCA), along with further evaluation of IgG autoantibodies (intrinsic factor and parietal cell antibodies). Concordance among methods was evaluated. Results IIFT detected anti-endomysium IgA autoantibodies in 100% (80/80) of celiac patients (in this cohort), with no positivity in controls. ELISA demonstrated that both tTG IgA and DGP autoantibodies were present in all celiac disease patients. All controls (n = 158) were ELISA-negative, indicating 100% specificity in both assays. Immunoblots revealed tTG IgA in 99% (79/80) of patients, while GAF-3X autoantibodies were detected in 94% (IgA) and 85% (IgG) of celiac patients. In addition, ASCA IgA autoantibodies were present in 31% of celiac disease patients, with minimal reactivity observed in controls. A Venn diagram illustrated high concordance among the assays for tTG autoantibody detection, reinforcing the reliability of this autoantibody marker. Conclusion The robust and consistent detection of celiac disease-specific autoantibodies, particularly tTG IgA and DGP autoantibodies, across multiple serological platforms underscores their diagnostic utility. The high concordance among these markers supports the potential of combined autoantibody testing to serve as a non-invasive alternative to biopsy, thereby enhancing clinical management of celiac disease.
Keywords: Celiac Disease, Autoantibodies, tissue transglutaminase, Deamidated gliadin peptides, Indirect immunofluorescence, ELISA, immunoblot, Tunisia
Received: 28 Apr 2025; Accepted: 02 Oct 2025.
Copyright: © 2025 Ghozzi, Kai, Seifert, Melayah, Mechi, Romdhani, Chedly and Ghedira. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Marco Kai, m.kai@euroimmun.de
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.